Yes associated protein is a poor prognostic factor in well-differentiated lung adenocarcinoma.
Authors:
- 1 December 2015
- journal article
- research article
- Vol. 8 (12) , 15933-9
Abstract
The Hippo pathway is a highly conserved potent regulator of cell growth and apoptosis including large tumor suppressor (LATS) and Yes-associated protein (YAP). LATS has been regarded as a tumor suppressor gene and YAP as either of a tumor suppressor gene or an oncogene. We investigated their expression in lung adenocarcinoma. YAP and LATS protein expression was assessed in 167 surgically resected lung adenocarcinomas and compared with clinicopathologic factors. Disease free survival and overall survival were also evaluated. YAP expression was noted in cytoplasm (48 cases; 28.7%), nuclear (34; 20.4%) and both locations (4; 2.4%). The nuclear expression was typically observed in well differentiated adenocarcinoma. LATS was expressed in cytoplasm when its signal is weak. Perinuclear expression of LATS was observed when it is strongly expressed. While cytoplasmic and nuclear YAP expressions were inversely related. In well differentiated adenocarcinoma patients, YAP nuclear expression was related with more frequent relapse. Both of nuclear YAP and LATS expression were more frequently observed in well differentiated adenocarcinoma. Furthermore, YAP expression exhibited more frequent relapse in well differentiated adenocarcinoma group. We suggest that YAP may act as an oncogene and predict poorer prognosis in well differentiated lung adenocarcinoma.Keywords
This publication has 17 references indexed in Scilit:
- The Hippo Pathway Effector Yap Controls Patterning and Differentiation of Airway Epithelial ProgenitorsDevelopmental Cell, 2014
- Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS ClassificationJournal of Thoracic Oncology, 2013
- LATS tumor suppressor: A new governor of cellular homeostasisCell Cycle, 2010
- Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancerCancer Science, 2010
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinomaLung Cancer, 2009
- Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 2009
- Expression of Yes-associated protein in common solid tumorsHuman Pathology, 2008
- Filling out the Hippo pathwayNature Reviews Molecular Cell Biology, 2007
- Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2001